[Sinovac Biotech Announces Request Hearing before Nasdaq Hearings Panel BEIJING, November 8, 2017 /PRNewswire/ -- Sinovac Biotech Ltd. (Nasdaq: SVA) (the “Company” or “Sinovac”), a leading provider of biopharmaceutical products in China, announced today that the Company submitted a request for a hear]
[Sinovac Biotech Announces Request Hearing before Nasdaq Hearings Panel BEIJING, November 8, 2017 /PRNewswire/ -- Sinovac Biotech Ltd. (Nasdaq: SVA) (the “Company” or “Sinovac”), a leading provider of biopharmaceutical products in China, announced today that the Company submitted a request for a hear]
[Sinovac Biotech Announces Receipt of Delisting Determination Letter from Nasdaq BEIJING, November 3, 2017 /PRNewswire/ -- Sinovac Biotech Ltd. (Nasdaq: SVA)(”Sinovac”), a leading provider of biopharmaceutical products in China, announced today that on November 1, 2017, the Company received a delisti]
[Sinovac Biotech Announces Receipt of Delisting Determination Letter from Nasdaq BEIJING, November 3, 2017 /PRNewswire/ -- Sinovac Biotech Ltd. (Nasdaq: SVA)(”Sinovac”), a leading provider of biopharmaceutical products in China, announced today that on November 1, 2017, the Company received a delisti]
[Sinovac Biotech Announces Certain Updates Relating to Delayed Filing of Annual Report on Form 20-F BEIJING, Aug. 14, 2017 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, announced today that The NASDAQ Stock ]
[Sinovac Biotech Announces Certain Updates Relating to Delayed Filing of Annual Report on Form 20-F BEIJING, Aug. 14, 2017 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, announced today that The NASDAQ Stock ]
[W ashington FORM 8-A Amendment No. 2 FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES SINOVAC BIOTECH LTD. Antigua, West Indies Not Applicable (State or other jurisdiction (I.R.S. Employer Identification of incorporation or organization) Number) No. 39 Shangdi Xi Road, Haidian District, Beijing 100]
[SINOVAC BIOTECH LTD. and PACIFIC STOCK TRANSFER COMPANY as Rights Agent SECOND AMENDMENT TO RIGHTS AGREEMENT Effective as of June 26, 2017 Amendment Rights Agreement Company Rights Agent Amalgamation Agreement Parent provided however This Second Amendment (this “ WHEREAS, the Company and the Rights ]
[SINOVAC BIOTECH LTD. and PACIFIC STOCK TRANSFER COMPANY as Rights Agent SECOND AMENDMENT TO RIGHTS AGREEMENT Effective as of June 26, 2017 Amendment Rights Agreement Company Rights Agent Amalgamation Agreement Parent provided however This Second Amendment (this “ WHEREAS, the Company and the Rights ]
[Joint Filing Agreement This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument. [Remainder of this page has been left intentionally blank.] SAIF Partners IV L.P. Andrew Y. Yan Director of SAIF IV GP Capital Ltd., which is]
